Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Mixed dementia: emerging concepts and therapeutic implications.

Langa KM, Foster NL, Larson EB.

JAMA. 2004 Dec 15;292(23):2901-8. Review.

PMID:
15598922
2.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
3.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
4.

Pharmacologic treatments of dementia.

Bonner LT, Peskind ER.

Med Clin North Am. 2002 May;86(3):657-74. Review.

PMID:
12171061
5.

Management of mixed dementia.

Zekry D, Gold G.

Drugs Aging. 2010 Sep 1;27(9):715-28. doi: 10.2165/11538250-000000000-00000. Review.

PMID:
20809662
6.

Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Levine DA, Langa KM.

Neurotherapeutics. 2011 Jul;8(3):361-73. doi: 10.1007/s13311-011-0047-z. Review.

7.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
8.

Use of antidementia agents in vascular dementia: beyond Alzheimer disease.

Farlow MR.

Mayo Clin Proc. 2006 Oct;81(10):1350-8. Review.

PMID:
17036561
9.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
10.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
11.

Neuroprotection in vascular dementia.

Martínez-Vila E, Murie-Fernández M, Gállego Pérez-Larraya J, Irimia P.

Cerebrovasc Dis. 2006;21 Suppl 2:106-17. Epub 2006 May 2.

PMID:
16651821
12.

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M.

Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. Review.

PMID:
16917181
13.

An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.

Erkinjuntti T, Kurz A, Small GW, Bullock R, Lilienfeld S, Damaraju CV; GAL-INT-6 Study Group.

Clin Ther. 2003 Jun;25(6):1765-82. Erratum in: Clin Ther. 2003 Aug;25(8):2336.

PMID:
12860497
14.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003154.

PMID:
15846650
15.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003154.

PMID:
16034889
16.

Memantine for dementia.

McShane R, Areosa Sastre A, Minakaran N.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154. Review.

PMID:
16625572
17.

Treatment of Alzheimer disease.

Winslow BT, Onysko MK, Stob CM, Hazlewood KA.

Am Fam Physician. 2011 Jun 15;83(12):1403-12. Erratum in: Am Fam Physician. 2014 Aug 15;90(4):209.

18.

Memantine: pharmacological properties and clinical uses.

Kumar S.

Neurol India. 2004 Sep;52(3):307-9. Review.

19.

Pharmacologic rationale for memantine in chronic cerebral hypoperfusion, especially vascular dementia.

Möbius HJ.

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S172-8. Review.

PMID:
10609698
20.

Diagnosis and management of vascular cognitive impairment and dementia.

Erkinjuntti T.

J Neural Transm Suppl. 2002;(63):91-109. Review.

PMID:
12597611

Supplemental Content

Support Center